US Patent Issued to Dicerna Pharmaceuticals on Sept. 15 for "Compositions and methods for inhibiting ANGPTL3 expression" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,710, issued on Sept. 15, was assigned to Dicerna Pharmaceuticals Inc. (Cambridge, Mass.).

"Compositions and methods for inhibiting ANGPTL3 expression" was invented by Bob D. Brown (Lexington, Mass.), Henryk T. Dudek (Belmont, Mass.), Utsav Saxena (Watertown, Mass.), Marc Abrams (Natick, Mass.) and Anton Turanov (Revere, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Oligonucleotides are provided herein that inhibit angiopoietin-like protein 3 (ANGPTL3) expression. Also provided are compositions including the same and uses thereof, particularly uses relating to treating diseases, disorders and/or conditions associated with ANGPTL3 expression."...